Emerging Pollutant of Concern: Occurrence of Pharmaceutical Compounds in Asia with Particular Preference to Southeast Asia Countries

Abstract

Abstract. Southeast Asia countries were developing countries, with the rapid development for a better living condition leads to longer life expectancy, which increased total population. It may result in increased the demand of pharmaceutical in domestic use and or in hospital. Although most wastewater treatment plants (WWTPs) met the local authority's regulatory requirement, there are still many pharmaceutical compound incompletely removed and discharge to the water stream and enter the environment. Recently many studies and researches have published on the occurrence and source as well as the fate of pharmaceuticals all over the world including Asia. As part of Asia region, Southeast Asia countries (Malaysia, Philippines, Singapore, Thailand, Vietnam, Brunei, Cambodia, and Lao PDR) seem has lack of research knowledge and information regarding this emerging pollutant issues compared to developed Asia country as China, Korea and Hong Kong. In this paper, it will review recent studies occurrences (surface and wastewater) on most common pharmaceuticals with several recommendations to overcome and thus summarise the actual situation in Southeast Asia.

Removal of Contaminants of Emerging Concern (CECs) Using a Membrane Bioreactor (MBR): a short review

“…CECs are manmade pollutants and still remained less significant than their potential impacts due to the detection of these chemicals at infinitesimal concentrations; from μg/L to ng/L across an array of ecosystems. Recently, environmental scientists have dealt with the occurrence of CECs in surface water, water supply, wastewater, groundwater and sewage sludge in various regions including European, Asian, American and even African communities (Jiang et al, 2013;Guo et al, 2014;Subedi et al, 2015;Hashim et al, 2016;Krogh et al, 2017;Kwon et al, 2017).…”

Emerging Pollutants in Developing Countries: Optimising Sustainable Treatment Solutions

“…Since 1965, there has been an increase in publications regarding pharmaceuticals and hormones in the water due to a noticed rise and increase in water pollution as a worldwide problem [8]. The problem with EPs is that they are not regularly monitored due to a lack of controlling requirements, legislations, and high analytical costs [9]. EPs are presented at low trace concentrations ranging from a few ng/L to several μg/L, with point source locations consisting of industrial effluents, wastewater and water treatment plants.…”